Evidence map›Paper›PMID 42647535›Full record

ArticlePLoS biology2026

Polymorphisms in a bacterial signalling pathway alter evolutionary routes of antibiotic resistance in Escherichia coli.

Chetna Yelpure, Saillesh Chinnaraj, Kush Topiwala, Jay Phadke, Nishad Matange

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chetna YelpureDepartment of Biology, Indian Institute of Science Education and Research (IISER), Pune, India.
Saillesh ChinnarajDepartment of Biology, Indian Institute of Science Education and Research (IISER), Pune, India.
Kush TopiwalaDepartment of Biology, Indian Institute of Science Education and Research (IISER), Pune, India.
Jay PhadkeDepartment of Biology, Indian Institute of Science Education and Research (IISER), Pune, India.
Nishad MatangeDepartment of Biology, Indian Institute of Science Education and Research (IISER), Pune, India.ORCID https://orcid.org/0000-0002-2947-3931

Funding

Wellcome Trust
6 · The paper itself

Abstract

Antibiotic resistance in bacteria frequently evolves due to mutations in drug-target or detoxifying genes. Pre-existing polymorphisms in these genes are likely to influence the evolvability of drug resistance. However, the role of polymorphisms in driving resistance evolution and the underlying molecular mechanisms are poorly understood. Here, we demonstrate that polymorphisms in a signalling pathway impact the evolvability of trimethoprim (TMP) resistance in Escherichia coli. When challenged with TMP, de-repression of the PhoQ-PhoP two-component signalling system in E. coli transcriptionally upregulates the drug target Dihydrofolate Reductase (DHFR), leading to drug resistance. We identified and characterised naturally occurring polymorphisms in PhoQ and DHFR that modulate intrinsic antibiotic susceptibility. These variants also altered the ability of E. coli to evolve de novo TMP resistance as a result of epistasis with adaptive mutations. Interestingly, a strain harbouring a less-evolvable DHFR variant acquired a novel mutation in PhoQ under TMP pressure that hyperactivated the signalling pathway, conferring high-level resistance but at a large fitness cost. This mutation was not observed in wild type but reached fixation rapidly in the background of the DHFR variant. Using RNA-sequencing we compare how natural variants and adaptive mutations in PhoQ affect the expression of PhoP-target genes and downstream regulatory pathways in E. coli. Finally, we uncouple the roles of resistance level by DHFR overproduction and fitness cost by activation of the RpoS regulon to explain why E. coli more frequently evolves to de-repress PhoQ than hyperactivate it under drug pressure. Our study, thus, demonstrates that pre-existing polymorphisms alter both, evolvability and mutation landscapes during antibiotic adaptation. This work establishes the PhoQ-PhoP-DHFR pathway as an experimental paradigm to understand the evolution of signalling pathways under environmental selection.

Indexed as

Drug Resistance, BacterialEscherichia coliPolymorphism, GeneticSignal TransductionAnti-Bacterial AgentsEpistasis, GeneticEscherichia coli ProteinsEvolution, MolecularGene Expression Regulation, BacterialMutationTetrahydrofolate DehydrogenaseTrimethoprimTrimethoprim ResistanceAnti-Bacterial AgentsEscherichia coli ProteinsPhoP protein, E coliPhoQ protein, E coliTetrahydrofolate DehydrogenaseTrimethoprim

Identifiers

PMID42647535
PMCPMC13529223

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.